CEO Medicines for Malaria Venture, MMV; Member of the Board, Coalition for Epidemic Preparedness Innovations, CEPI
Dr David Reddy is CEO of Medicines for Malaria Venture, a leading not-for-profit product development partnership (PDP) in antimalarial drug research. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs. David has over 25 years’ experience in the development and commercialization of medicines for the treatment of infectious diseases, specializing in priority diseases such as HIV/AIDS and pandemic influenza. He is on the Board of the Coalition for Epidemic Preparedness Innovations (CEPI), the RBM Partnership to End Malaria and of the Board of Trustees of Malaria No More UK.